Can spontaneous adverse event reporting systems really be used to compare rates of adverse events between drugs?

被引:10
|
作者
Mertes, Paul M. [1 ]
Guttormsen, Anne B.
Harboe, Torkel
Johansson, S. Gunnar O.
Florvaag, Erik
Husum, Bent
Garvey, Lene H.
Kroigaard, Morgens
Gramstad, Lars
Kvande, Kristin T.
Trechot, Philippe
Malinovsky, Jean M.
机构
[1] CHU Nancy, Hop Cent, Serv Anesthesie Reanimat Chirurg, Nancy, France
[2] Haukeland Hosp, Dept Anesthesia & Intens Care, Bergen, Norway
[3] Karolinska Univ Hosp, Clin Immunol & Allergy Unit, Dept Med, Stockholm, Sweden
[4] Haukeland Hosp, Lab Clin Biochem, Dept Occupat Med, Bergen, Norway
[5] Haukeland Hosp, Sect Clin Allergol, Bergen, Norway
[6] Norwegian Med Agcy, Oslo, Norway
[7] CHU Nancy, Hop Cent, Ctr Pharmacovigilance Nancy, Nancy, France
[8] Hop Maison Blanche, Dept Anesthesie Reanimat, Reims, France
来源
ANESTHESIA AND ANALGESIA | 2007年 / 104卷 / 02期
关键词
D O I
10.1213/01.ane.0000253671.90500.0b
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:471 / 472
页数:2
相关论文
共 50 条
  • [21] An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions
    Vinther, Siri
    Klarskov, Pia
    Borgeskov, Hanne
    Darso, Perle
    Christophersen, Anette Kvindebjerg
    Borck, Bille
    Christensen, Catrine
    Hansen, Melissa Voigt
    Halladin, Natalie Monica Lovland
    Christensen, Mikkel Bring
    Harboe, Kirstine Moll
    Lund, Marie
    Jimenez-Solem, Espen
    DANISH MEDICAL JOURNAL, 2017, 64 (01):
  • [22] ASSESSING THE ASSOCIATION OF OMALIZUMAB USE AND ARTERIOTHROMBOTIC EVENTS THROUGH SPONTANEOUS ADVERSE EVENT REPORTING
    Ali, A. K.
    VALUE IN HEALTH, 2012, 15 (04) : A51 - A51
  • [23] Spontaneous reporting of rare events associated with atypical antipsychotics using the FDA adverse event reporting system
    Emechebe, Nnadozie
    Mukhtar, Fahad
    Scheer, Darren
    Patel, Arshiya
    Wadhawan, Abhishek
    Schwartz, Skai
    Zgibor, Janice
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 345 - 346
  • [24] Evaluation of spontaneous adverse event reports for kidney injury attributed to atezolizumab within the FDA adverse events reporting system
    Zaafan, Ola
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 460 - 460
  • [25] Pattern of adverse events induced by aflibercept and ranibizumab A nationwide spontaneous adverse event reporting database, 2007-2016
    Ha, Dongmun
    Choi, So-Ra
    Kwon, Yongmin
    Park, Han-Heui
    Shin, Ju-Young
    MEDICINE, 2019, 98 (33)
  • [26] A Review of Dental Adverse Events Using the FDA Adverse Event Reporting System
    Altman, Keith
    Budny, Renata
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 400 - 400
  • [27] A Standardized Dataset of a Spontaneous Adverse Event Reporting System
    Khaleel, Mohammad Ali
    Khan, Amer Hayat
    Ghadzi, Siti Maisharah Sheikh
    Adnan, Azreen Syazril
    Abdallah, Qasem M.
    HEALTHCARE, 2022, 10 (03)
  • [28] A Pattern Discovery Framework for Adverse Event Evaluation and Inference in Spontaneous Reporting Systems
    Markatou, Marianthi
    Ball, Robert
    STATISTICAL ANALYSIS AND DATA MINING, 2014, 7 (05) : 352 - 367
  • [29] Evaluation of Spontaneous Adverse Event Reports for Muscle Related Adverse Reactions Attributed to Daptomycin within the FDA Adverse Events Reporting System (FAERS)
    Khedr, Ola F.
    Shokr, Hala
    Mekkawy, Mohamed A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 315 - 315
  • [30] Gender differences in the adverse events induced by cardiovascular drugs: Using National Adverse Event Reporting and health insurance database
    Park, Han-Heui
    Yoon, Dongwon
    Kim, Ju Hwan
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 560 - 560